On April 30, 2026, the U.S. Department of Education finalized the Reimagining and Improving Student Education (RISE) rule, which caps federal student loans for graduate students at $20,500 per academic year. For students enrolled in doctoral-level programs — including Doctor of Nursing Practice (DNP) programs — total federal borrowing is limited to $100,000. The rule takes effect July 1, 2026.

The practical impact on nursing: MSN and DNP programs, which were previously classified as professional-degree programs eligible for higher Grad PLUS loan limits, are reclassified under the RISE rule. DNP programs cost $60,000–$150,000 depending on institution; average program costs at private universities frequently exceed the new $100,000 lifetime cap. MSN programs run $30,000–$80,000 at most institutions, making the $20,500/year cap tight for full-time students at higher-cost programs.

What the rule actually changes

Under prior rules, graduate students in professional programs — law, medicine, dentistry, and nursing — could borrow up to the full cost of attendance via Grad PLUS loans. The RISE rule replaces the professional-degree classification with a new framework that caps annual borrowing at $20,500 for most graduate students.

For a DNP student at a program that costs $45,000/year, that means a $24,500/year gap. Students will be forced to fill that gap with private loans (which carry higher interest rates and fewer repayment protections than federal loans) or out-of-pocket payment. Students who started programs before July 1, 2026 are not grandfathered — the rule applies to new loan disbursements beginning with the 2026–2027 academic year.

Nursing organizations push back

Six nursing and nurse practitioner associations issued a joint statement calling the reclassification “profoundly dismaying” and warning that it will reduce the pipeline of advanced practice nurses at a time when NP workforce shortages are well-documented. The American Association of Nurse Practitioners, American Association of Colleges of Nursing, and National Organization of Nurse Practitioner Faculties were among the signatories.

The core argument is structural: NP and DNP graduates fill primary care and specialty access gaps in rural and underserved communities. Raising the effective cost of DNP education through private loan substitution will reduce enrollment among applicants without existing wealth — disproportionately nurses from low-income backgrounds and those making mid-career transitions from bedside to advanced practice. The $100,000 lifetime federal cap does not reflect the actual cost of the programs the federal government is nominally encouraging nurses to pursue.

What this means for nurses considering APRN programs

If you are currently planning to enroll in an MSN or DNP program and have not yet secured financial aid for the 2026–2027 year, July 1 is your hard deadline for understanding your actual funding picture. Federal Direct Unsubsidized Loans at $20,500/year are still available; what changes is access to Grad PLUS for amounts above that cap.

Nurse loan forgiveness programs remain available and are not affected by the RISE rule. Public Service Loan Forgiveness (PSLF) covers DNP-level federal loans if you work at a qualifying nonprofit hospital or government employer for 10 years. If you work in primary care or in a health shortage area, the NHSC Loan Repayment Program offers up to $50,000 in loan repayment in exchange for a two-year service commitment. The loan forgiveness checker helps identify which programs you qualify for based on your employer type and state.

Nursing school financial aid offices are still digesting the full implications of RISE, and guidance on institutional aid adjustments has been uneven. Talk directly to your program's financial aid office before assuming your existing aid award will cover the gap — many schools have not yet updated their 2026–2027 cost-of-attendance models to reflect the new borrowing limits.

The workforce pipeline argument

The nursing organizations opposing the RISE rule are making a workforce argument, not just a financial aid argument. The country needs roughly 275,000 additional APRNs by 2030 to meet projected demand for primary care and specialty services in underserved communities. That pipeline is built through MSN and DNP programs. Policies that raise the effective cost of those programs — by forcing students into higher-cost private borrowing — reduce the number of candidates who can financially sustain the educational investment, particularly those entering from bedside nursing where savings rates are limited and existing student loan debt from initial RN education is common.

Proponents of the RISE rule argue that graduate program cost inflation has been driven partly by unconstrained federal loan availability, and that putting discipline into the borrowing market will encourage programs to reduce costs. That may be true at the margin over time, but it does not help nurses making enrollment decisions for the 2026–2027 academic year who now face a funding gap that did not exist in their financial planning assumptions. The rule is finalized. Advocacy for changes will take legislative action or a future rulemaking process — neither of which will help nurses enrolling this fall.